Enovis
ENOV

Enovis (ENOV) analyst forecast and price target

Analyst forecast

Buy

Consensus of 13 analyst ratings

Buy
12
Hold
1
Sell
0
Average price target
$39.33+60.25% vs. last price
Last $24.55
Low $29.00High $51.00

Based on 6 analyst targets

Recent analyst ratings

FirmActionRatingPrice targetDate
Canaccord GenuityMaintainedBuy$45.00 from $50.00Aug 17, 2026
Wells FargoMaintainedOverweight$39.00 from $40.00Aug 7, 2026
BTIGMaintainedBuy$40.00 from $39.00Aug 6, 2026
UBSInitiated CoverageBuy$51.00 from $50.00Jul 28, 2026
BMO CapitalInitiated CoverageOutperform$29.00Jul 9, 2026
Evercore ISI GroupMaintainedOutperform$32.00 from $36.00Jul 6, 2026
BTIGMaintainedBuy$39.00May 22, 2026
Wells FargoMaintainedOverweight$40.00 from $42.00May 8, 2026
Evercore ISI GroupMaintainedOutperform$36.00 from $35.00May 8, 2026
William BlairInitiated CoverageOutperformApr 17, 2026
Evercore ISI GroupMaintainedOutperform$35.00 from $36.00Apr 6, 2026
BTIGMaintainedBuy$43.00 from $41.00Feb 26, 2026
NeedhamMaintainedBuy$52.00 from $49.00Feb 26, 2026
BTIGInitiated CoverageBuy$41.00Jan 6, 2026
Canaccord GenuityMaintainedBuy$50.00 from $58.00Dec 17, 2025
Freedom Capital MarketsInitiated CoverageBuy$45.00Dec 17, 2025
Wells FargoMaintainedOverweight$42.00 from $41.00Nov 7, 2025
Wells FargoMaintainedOverweight$41.00 from $48.00Aug 8, 2025
UBSMaintainedBuy$57.00 from $65.00Aug 8, 2025
Canaccord GenuityMaintainedBuy$58.00 from $70.00Aug 8, 2025

Frequently asked questions

  • What is the price target for ENOV stock?

    The average 12-month analyst price target for Enovis (ENOV) is $39.33, with a high estimate of $51.00 and a low of $29.00, across 6 analysts.

  • Is ENOV a buy, sell, or hold?

    Analysts covering Enovis currently average a Buy rating: 12 buy, 1 hold and 0 sell, from 13 analysts. Ratings reflect analyst opinion, not investment advice.

  • What upside do analysts see for ENOV?

    The average price target of $39.33 implies 60.25% upside from the last price of $24.55.

  • What is the latest analyst rating on ENOV?

    On Aug 17, 2026, Canaccord Genuity maintained Enovis at Buy with a price target of $45.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.